Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 October 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 190 pages)

 

Export 8 results:
Author Title [ Type(Desc)] Year
Filters: Author is Brophy, J. M.  [Clear All Filters]
Journal Article
S. Y. Loo, Coulombe, J., Dell'Aniello, S., Brophy, J. M., Suissa, S., and Renoux, C., Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study, BMJ Open, vol. 8, p. e019638, 2018.
S. S. Daskalopoulou, Delaney, J. A., Filion, K. B., Brophy, J. M., Mayo, N. E., and Suissa, S., Discontinuation of statin therapy following an acute myocardial infarction: a population-based study, Eur Heart J, vol. 29, pp. 2083-91, 2008.
C. Renoux, Dell'Aniello, S., Brophy, J. M., and Suissa, S., Dopamine agonist use and the risk of heart failure, Pharmacoepidemiol Drug Saf, vol. 21, pp. 34-41, 2012.
J. A. Delaney, Opatrny, L., Brophy, J. M., and Suissa, S., Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding, Cmaj, vol. 177, pp. 347-51, 2007.
K. B. Filion, Delaney, J. A., Brophy, J. M., Ernst, P., and Suissa, S., The impact of over-the-counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research Database, Pharmacoepidemiol Drug Saf, vol. 16, pp. 1-4, 2007.
J. A. Delaney, Daskalopoulou, S. S., Brophy, J. M., Steele, R. J., Opatrny, L., and Suissa, S., Lifestyle variables and the risk of myocardial infarction in the general practice research database, BMC Cardiovasc Disord, vol. 7, p. 38, 2007.
K. B. Filion, Joseph, L., Boivin, J. F., Suissa, S., and Brophy, J. M., Thiazolidinediones and the risk of incident congestive heart failure among patients with type 2 diabetes mellitus, Pharmacoepidemiol Drug Saf, vol. 20, pp. 785-96, 2011.
K. B. Filion, Joseph, L., Boivin, J. F., Suissa, S., and Brophy, J. M., Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis, Pharmacoepidemiol Drug Saf, vol. 18, pp. 973-6, 2009.
[Page last reviewed 4 October 2019]